Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
4(80.0%)
Phase 1
1(20.0%)
5Total
N/A(4)
Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT06243783Not ApplicableRecruiting

Impact of Stress on Brain Energy Metabolism

Role: lead

NCT05320120Phase 1Completed

Investigation of Intranasal Ketamine Related Changes in Attentional Brain Networks With Functional and Structural MRI

Role: lead

NCT03485066Not ApplicableUnknown

Simultaneous PET/MR Imaging of Human Brain Plasticity

Role: lead

NCT03257397Not ApplicableUnknown

TBS in Major Depression

Role: lead

NCT02810717Not ApplicableUnknown

Effects of TBS on 5-HT1A Receptor Binding

Role: lead

All 5 trials loaded